tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TSE:NRX Stock Latest News

NurExone Biologic Advances Exosome Therapy with Key Acquisition
Company AnnouncementsNurExone Biologic Advances Exosome Therapy with Key Acquisition
1d ago
NurExone Reports Breakthrough in Vision Restoration
PremiumCompany Announcements
NurExone Reports Breakthrough in Vision Restoration
1M ago
NurExone’s Financial Gains and Strategic Progress
PremiumCompany Announcements
NurExone’s Financial Gains and Strategic Progress
1M ago
NRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
NurExone Gains Key EMA Status for ExoPTEN
PremiumCompany Announcements
NurExone Gains Key EMA Status for ExoPTEN
2M ago
NurExone Biologic Secures Funding and Expands Market Presence
PremiumCompany AnnouncementsNurExone Biologic Secures Funding and Expands Market Presence
2M ago
NurExone’s Innovative Therapies Gain Recognition
Premium
Company Announcements
NurExone’s Innovative Therapies Gain Recognition
3M ago
NurExone Biologic’s $2M Capital Raise Advances Therapy Development
Premium
Company Announcements
NurExone Biologic’s $2M Capital Raise Advances Therapy Development
4M ago
NurExone Biologic to Showcase Exosome Therapies Globally
PremiumCompany Announcements
NurExone Biologic to Showcase Exosome Therapies Globally
4M ago
NurExone’s Breakthrough Extends Spinal Injury Treatment Window
PremiumCompany Announcements
NurExone’s Breakthrough Extends Spinal Injury Treatment Window
4M ago
NurExone Biologic Inc. Showcases Corporate Growth and Q2 Results
PremiumCompany Announcements
NurExone Biologic Inc. Showcases Corporate Growth and Q2 Results
4M ago
NurExone Spotlights ExoPTEN Therapy at Key Conferences
PremiumCompany Announcements
NurExone Spotlights ExoPTEN Therapy at Key Conferences
5M ago
NurExone Biologic Advances in Exosome Production
PremiumCompany AnnouncementsNurExone Biologic Advances in Exosome Production
5M ago
NurExone’s ExoPTEN Shows Precise Injury Targeting
Premium
Company Announcements
NurExone’s ExoPTEN Shows Precise Injury Targeting
5M ago
NurExone Advances ExoPTEN Drug Towards Clinical Trials
Premium
Company Announcements
NurExone Advances ExoPTEN Drug Towards Clinical Trials
5M ago
NurExone Biologic Expands Patent Portfolio and Partnerships
PremiumCompany Announcements
NurExone Biologic Expands Patent Portfolio and Partnerships
5M ago
NurExone’s ExoPTEN Shows Promise for Glaucoma Treatment
PremiumCompany Announcements
NurExone’s ExoPTEN Shows Promise for Glaucoma Treatment
6M ago
NurExone Unveils Website and Conference Spotlight
PremiumCompany Announcements
NurExone Unveils Website and Conference Spotlight
6M ago
NurExone Targets Vision Loss with ExoPTEN Therapy
PremiumCompany Announcements
NurExone Targets Vision Loss with ExoPTEN Therapy
7M ago
NurExone Biologic Uplifted by Drug Development Expert
PremiumCompany AnnouncementsNurExone Biologic Uplifted by Drug Development Expert
7M ago
NurExone Secures Japanese Patent for ExoPTEN
Premium
Company Announcements
NurExone Secures Japanese Patent for ExoPTEN
7M ago
NurExone Shareholders Back Key Resolutions
Premium
Company Announcements
NurExone Shareholders Back Key Resolutions
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >